Today: 8 February 2026
Subscribe
Browse Category

ASX:EDV News 13 January 2026

Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide

Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide

Australian shares closed up 0.56% at 8,808.50, led by gains in miners and banks, while energy stocks fell. BHP rose 2.3%, Rio Tinto 2.2%, and Endeavour Group dropped 2.9% on margin pressure. GQG Partners slid 8.6% after reporting US$2.1 billion in December net outflows. Investors await U.S. inflation data due Wednesday.
13 January 2026
·······

Stock Market Today

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

8 February 2026
London Stock Exchange Group shares fell 1.1% to 7,502p Friday, closing out a third straight weekly decline and an 8% drop for the week. The selloff followed renewed concerns over AI disruption after a new Claude plug-in from Anthropic and caution over Big Tech’s AI spending. LSEG bought back 256,419 shares on Feb. 5. Investors await Monday’s open and LSEG’s FY25 results webcast on Feb. 26.
Anglo American share price slips after BofA downgrade as De Beers review looms

Anglo American share price slips after BofA downgrade as De Beers review looms

8 February 2026
Anglo American shares closed at 3,435 pence on Friday, down 0.75%, after BofA Global Research downgraded the miner to “neutral” over valuation and execution risks. The bank raised its price target to 3,600 pence but flagged a long wait for Teck synergies and uncertainty around De Beers. Investors await full-year results and updates on deals and disposals on Feb. 20.
GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

8 February 2026
GSK shares closed Friday up 0.8% at 2,198 pence after the EU approved expanded use of Nucala for adults with uncontrolled COPD. Chairman Jonathan Symonds bought 2,500 shares earlier in the week. The stock is up 17% over the past week and nearly 49% in 12 months. GSK trades ex-dividend on Feb. 19.
Go toTop